Grant: Collaborative Health Research Projects
École Polytechnique de Montréal
$73,000.00
Novel nanocolloids photosensitizers produced by femtosecond laser ablation in aqueous solutions for tasks of cancer therapy
EF 2008-09
Résumé
Despite significant recent progress in the treatment and prevention of cancer, this illness remains one of the major threats and is responsible for almost 25% of all deaths annually in western countries. This pessimistic statistics stimulates a search of novel methods for detection and treatment of cancer which could offer improved sensitivity, specificity, and cost-effectiveness. Significant expectations are now related to emerging photonics-based technologies for tasks of cancer detection and treatment, promising high resolution, noninvasive functional imaging of tissue at competitive costs. For endogenous chromophores, however, these technologies are limited by poor properties of organic materials. Inorganic-based nanocolloids photosensitizers (NCPS) are known to provide much more stable and promising characteristics. However, the clinical applications of these NCPS are still in question because of their toxicity, resulting from the respective chemical fabrication procedure. The Collaborative Health Research Project proposal promises a solution of the toxicity problem by using a quite novel class of inorganic photosensitizers. Such photosensitizers will be produced by a novel femtosecond laser ablation-based method, which was recently introduced by the project participants. The method enables to fabricate semiconductor or metal-based NCPS in contamination-free biocompatible aqueous solutions. In the frame of the project, we will further elaborate the laser ablation-based methodology to fabricate of semiconductor-based NCPS and metal nanostructures (e.g. nanoshells) with desired optical and chemical characteristics. We will then perform long-term stability and toxicity tests of the newly synthesized materials and apply these NCPS in PDT and thermal therapies of cancer in basic in vitro and in vivo models. A multidisciplinary team from École Polytechnique and the Ontario Cancer Institute, comprising experts in laser nanofabrication technologies, nanophotonics, PDT and thermal therapy of cancer will joined their efforts to perform this research in collaboration with our industrial partner, Theralase Inc.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
323592-2006
Name nom
Meunier, Michel
Department département
Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
73000
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
3
Nb partie
3
Application title
Novel nanocolloids photosensitizers produced by femtosecond laser ablation in aqueous solutions for tasks of cancer therapy
Keyword
NA
Application summary
Despite significant recent progress in the treatment and prevention of cancer, this illness remains one of the major threats and is responsible for almost 25% of all deaths annually in western countries. This pessimistic statistics stimulates a search of novel methods for detection and treatment of cancer which could offer improved sensitivity, specificity, and cost-effectiveness. Significant expectations are now related to emerging photonics-based technologies for tasks of cancer detection and treatment, promising high resolution, noninvasive functional imaging of tissue at competitive costs. For endogenous chromophores, however, these technologies are limited by poor properties of organic materials. Inorganic-based nanocolloids photosensitizers (NCPS) are known to provide much more stable and promising characteristics. However, the clinical applications of these NCPS are still in question because of their toxicity, resulting from the respective chemical fabrication procedure. The Collaborative Health Research Project proposal promises a solution of the toxicity problem by using a quite novel class of inorganic photosensitizers. Such photosensitizers will be produced by a novel femtosecond laser ablation-based method, which was recently introduced by the project participants. The method enables to fabricate semiconductor or metal-based NCPS in contamination-free biocompatible aqueous solutions. In the frame of the project, we will further elaborate the laser ablation-based methodology to fabricate of semiconductor-based NCPS and metal nanostructures (e.g. nanoshells) with desired optical and chemical characteristics. We will then perform long-term stability and toxicity tests of the newly synthesized materials and apply these NCPS in PDT and thermal therapies of cancer in basic in vitro and in vivo models. A multidisciplinary team from École Polytechnique and the Ontario Cancer Institute, comprising experts in laser nanofabrication technologies, nanophotonics, PDT and thermal therapy of cancer will joined their efforts to perform this research in collaboration with our industrial partner, Theralase Inc.